No significant effect of antimicrobial treatment on Stenotrophomonas maltophilia pneumonia outcome.
Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study.
Rédigé par : Dr Olivier Leroy
Although S. maltophilia is regularly identified as the causal agent of nosocomial pneumonia, the optimal modalities of antimicrobial therapy remain to be determined. Hence the idea of this study.
Methods
This nationwide retrospective study included all patients admitted to 25 French mixed intensive care units (belonging to AZUREA research network) between 2012 and 2017 with...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.
This content is intended for healthcare professionals. Thank you for identifying yourself.
Déjà inscrit / Already registered ?
Créer un compte / Create an account
Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.